These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 25980003
1. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients. Montoya AM, Sánchez González A, Palma-Nicolás JP, Gómez-Treviño A, González JG, González GM. Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003 [Abstract] [Full Text] [Related]
2. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina. Taverna CG, Córdoba S, Murisengo OA, Vivot W, Davel G, Bosco-Borgeat ME. Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113 [Abstract] [Full Text] [Related]
3. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. Sun W, Su J, Xu S, Yan D. J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749 [Abstract] [Full Text] [Related]
4. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece. Arabatzis M, Abel P, Kanellopoulou M, Adamou D, Alexandrou-Athanasoulis H, Stathi A, Platsouka E, Milioni A, Pangalis A, Velegraki A. Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082 [Abstract] [Full Text] [Related]
5. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen. Dabas Y, Xess I, Kale P. Med Mycol; 2017 Jul 01; 55(5):518-527. PubMed ID: 27816903 [Abstract] [Full Text] [Related]
6. Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China. Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, Xiao M, Wang H, Barresi C, Zhou ML, de Hoog GS, Xu YC. J Clin Microbiol; 2019 Feb 01; 57(2):. PubMed ID: 30463892 [Abstract] [Full Text] [Related]
7. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, de Tarso O Castro P, Guimarães T, Hahn RC, Padovan ACB, Chaves GM, Colombo AL. Clin Microbiol Infect; 2019 Jul 01; 25(7):909.e1-909.e5. PubMed ID: 30991116 [Abstract] [Full Text] [Related]
8. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India. Rastogi V, Honnavar P, Rudramurthy SM, Pamidi U, Ghosh A, Chakrabarti A. Mycoses; 2016 Aug 01; 59(8):528-34. PubMed ID: 27144725 [Abstract] [Full Text] [Related]
9. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Xia Z, Yang R, Wang W, Cong L. Mycopathologia; 2012 Mar 01; 173(2-3):127-33. PubMed ID: 21979867 [Abstract] [Full Text] [Related]
10. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. J Clin Microbiol; 2009 Apr 01; 47(4):1074-81. PubMed ID: 19225102 [Abstract] [Full Text] [Related]
11. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Rev Iberoam Micol; 2008 Dec 31; 25(4):221-5. PubMed ID: 19071890 [Abstract] [Full Text] [Related]
12. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin. Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH. Virulence; 2015 Dec 31; 6(5):476-86. PubMed ID: 25751127 [Abstract] [Full Text] [Related]
13. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Tsai MS, Yang YL, Wang AH, Wang LS, Lu DC, Liou CH, Hsieh LY, Wu CJ, Cheng MF, Shi ZY, Lo HJ. Mycopathologia; 2012 Aug 31; 174(2):121-30. PubMed ID: 22318636 [Abstract] [Full Text] [Related]
14. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. Guo LN, Xiao M, Kong F, Chen SC, Wang H, Sorrell TC, Jiang W, Dou HT, Li RY, Xu YC. J Clin Microbiol; 2011 Nov 31; 49(11):3805-11. PubMed ID: 21900517 [Abstract] [Full Text] [Related]
15. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan. Yang YL, Liu YW, Chen HT, Tsai MS, Chu WL, Lo HJ. Med Mycol; 2013 Nov 31; 51(8):880-3. PubMed ID: 23768241 [Abstract] [Full Text] [Related]
16. First genotype identification of Trichosporon asahii in Sfax, Tunisia. Sellami H, Trabelsi H, Neji S, Amouri I, Cheikhrouhou F, Makni F, Ayadi A. J Med Microbiol; 2017 Apr 31; 66(4):397-401. PubMed ID: 28141498 [Abstract] [Full Text] [Related]